BRIEF: Wai Yuen Tong profit rises six-fold on non-operational gains
Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) announced on Wednesday its revenue fell 5.8% year-on-year to HK$347 million ($45 million) in the six months to…
RELATED ARTICLES
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK -
Yan Palace flies back to profit growth as revenue sags
1497.HK
- TCMTech fuses old with the new by mixing AI and Chinese medicine
-
NaaS drives into third quarter with first-ever quarterly non-IFRS profit
NAAS.US
-
Bumper dividend could trigger buyout for Ping An Health
1833.HK
-
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK ONC.US 688235.SHG
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
